Clinical Trials

Text Size A A

E-Mail to a Friend

secret  Click to Play Audio


Seattle Cancer
Care Alliance

SCCA has over 200 clinical trials open for patients and intends to lead the world in translating scientific discovery into the prevention, diagnosis, treatment and cure of cancer.

Recently Opened Trials

Tumor-Infiltrating Lymphocytes (TIL) for Metastatic Melanoma (2643)

Cellular Adoptive Immunotherapy Using Autologous Tumor-Infiltrating Lymphocytes Following Lymphodepletion With Cyclophosphamide and Fludarabine For Patients With Metastatic Melanoma

SGN-CD33A for Newly Diagnosed Acute Myeloid Leukemia (9233)

A phase 1b dose-escalation study of SGN-CD33A in combination with standard-of-care for patients with newly diagnosed acute myeloid leukemia (AML)

NY-ESO-1-specific T Cells for Metastatic NY-ESO-1-Expressing Sarcomas (2721)

A pilot trial of NY-ESO-1-specific T cells in patients with metastatic NY-ESO-1-expressing sarcomas receiving palliative radiation

MK-3475 for Advanced Merkel Cell Carcinoma (8269a)

A Phase II Study of MK-3475 in Patients with Advanced Merkel Cell Carcinoma (MCC)

Vaccine Therapy for HER2-Negative Stage III-IV Breast Cancer (9140)

A Phase I Trial of the Safety and Immunogenicity of a Multiple Antigen Vaccine (STEMVAC) in HER2 Negative Advanced Stage Breast Cancer Patients